HPV vaccines
Bethesda system
Squamous cell cc
Adenocc
Richard system
Papanicolou system
Reagan system (WHO)
RMI score
Risk of malignancy index for ovarian masses
- Menopausal status (pre=1p, post=3p)
- US morphology (multiloculated, solid areas, bilateral, ascites, intraabd metastases. Score 0-1 => U=1p, Score 2-5 => U=3p)
- CA-125 absolute value
MxUxCA125 = ? (over 200 is suspicious)
ROMA score ovarian masses
Treatment ovarian cc
Requires surgical exploration and intraop. frozen section
Stage
- IA: TAH-BSO (pregnancy-wish: USO=>fast pregnancy=>TAH-BSO)
- IB: TAH-BSO
- IC: TAH-BSO + peritoneal radioactive phosphorous
- II-IV: TAH-BSO + omentectomy + debulking (cytoreductive surgery) + chemo (paclitaxel+carboplatin)
*Bevacizumab (anti-VEGF) might be added adjuvantly
Germ-cell tumors and Sex-cord stromal tumors: TAH-BSO + staging +/- adjuvant BEP (bleomycin, etopocide, cisplatin)
Treatment uterine cc
Stage I-II: TAH-BSO (fertility-sparing: medroxyprogesterone acetate)
Stage III-IV: TAH-BSO + radiation + platinums
Treatment cervical cc
Stage Ia1: TAH (fertility-sparing: conization)
Stage IIa: TARH + PLND (fertility-sparing: up to Ib1: radical trachelectomy + PLND)
Stage IIb-IIIb: Radiation + chemo (cisplatin, bleomycin, mitomycin C, methotrexate, cyclophosphamide)
Stage IV: Palliative chemo/radiation/surgery
Types of vaginal prolapse
Uterine prolapse defects
- Uterosacral ligaments
Treatment vaginal prolapse
Treatment uterine prolapse
Treatment UTIs
Uncomplicated cystitis:
- Nitrofurantoin for 5 days -or- Trimethoprim/Sulfamethoxazole for 3 days
Acute pyelonephritis:
Treatment PID inpatient
Treatment PID outpatient
Alkylating agents
Cyclophosphamide
Antimetabolites
Antibiotics
Plant alkaloids
Paclitaxel: breast, ovarian, vaginal/vulvar cc
Platinum chemo
- Carboplatin: ovarian cc, uterine cc
Cell-cycle specific chemo
Normal sperm and semen